2019
DOI: 10.1016/j.bioorg.2019.03.046
|View full text |Cite
|
Sign up to set email alerts
|

Novel 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as potent human adenosine A1 and A2A receptor antagonists. Evaluation of their protective effect against β-amyloid-induced neurotoxicity in SH-SY5Y cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
13
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
2

Relationship

3
5

Authors

Journals

citations
Cited by 13 publications
(13 citation statements)
references
References 40 publications
0
13
0
Order By: Relevance
“…A 2A receptor blockade also neuroprotects these cells against neurotoxicity induced by α-synuclein, which is involved in PD [41]. In addition, A 1 and A 2A receptors have been also involved in neuroprotection against β-amyloid peptide neurotoxicity, which is related to AD [38,40], and in the neuroprotective action evoked by fullerene nanoparticles against hypoxic insult [39].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…A 2A receptor blockade also neuroprotects these cells against neurotoxicity induced by α-synuclein, which is involved in PD [41]. In addition, A 1 and A 2A receptors have been also involved in neuroprotection against β-amyloid peptide neurotoxicity, which is related to AD [38,40], and in the neuroprotective action evoked by fullerene nanoparticles against hypoxic insult [39].…”
Section: Discussionmentioning
confidence: 99%
“…Adenosine regulates neuroplasticity, cognitive and motor function, and emotion behaviors and it is related to many cerebral dysfunctions in human diseases [30,31]. Additionally, adenosine receptors function and level have been involved in neuroprotective and antitumoral mechanisms in C6 [32,33,34,35,36,37] and SH-SY5Y cells [32,38,39,40,41].…”
Section: Introductionmentioning
confidence: 99%
“…Our efforts in the pursuit of novel AR antagonists have centered on mono- or bicyclic heteroaromatic systems. [ 26 , 27 , 28 , 29 , 30 ]. Within this research, an interesting class of antagonists/inverse agonists (i.e., the thiazolo[5,4-d]pyrimidine series) was identified [ 31 , 32 , 33 , 34 , 35 ].…”
Section: Introductionmentioning
confidence: 99%
“…Indeed, four A2A AR antagonists, including Preladenant [17], PBF-509 [18], CPI-444 [19], and AZD4635 [20] have entered clinical development as anticancer drugs alone and in combination with other agents (Figure 1). Our group previously synthesized some potent human (h) A2A AR antagonists/inverse agonists belonging to different chemical classes [21][22][23][24][25][26][27][28][29][30][31]. Among these, the thiazolo [5,4-d]pyrimidine one (TP series) has been deeply investigated allowing us to delineate comprehensive structure activity relationships [21,[25][26][27]31].…”
Section: Introductionmentioning
confidence: 99%
“…Our group previously synthesized some potent human (h) A 2A AR antagonists/inverse agonists belonging to different chemical classes [ 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 ]. Among these, the thiazolo[5,4- d ]pyrimidine one (TP series) has been deeply investigated allowing us to delineate comprehensive structure activity relationships [ 21 , 25 , 26 , 27 , 31 ].…”
Section: Introductionmentioning
confidence: 99%